| Q79218992 | American Association of Clinical Endocrinologists Medical Guidelines for the Clinical Use of Dietary Supplements and Nutraceuticals |
| Q46955302 | An acute stressor enhances sensitivity to a chemical irritant and increases 51CrEDTA permeability of the colon in adult rats |
| Q35201118 | Clinical evidence for enteral nutritional support with glutamine: a systematic review |
| Q26797452 | Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis |
| Q34228766 | Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial |
| Q24186158 | Glutamine for induction of remission in Crohn's disease |
| Q24242201 | Glutamine for induction of remission in Crohn's disease |
| Q34027864 | Glutamine for the gut: mystical properties or an ordinary amino acid? |
| Q73931102 | Glutamine regulation of human immune cell function |
| Q35585329 | Glutamine supplementation in sick children: is it beneficial? |
| Q46632537 | Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease |
| Q79320465 | Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation? |
| Q38113765 | Mitochondria: sensors and mediators of innate immune receptor signaling. |
| Q22250970 | Nutrition and adult inflammatory bowel disease |
| Q48895847 | Nutritional consequences and nutrition therapy in Crohn's disease |
| Q41060588 | Nutritional management of adults with inflammatory bowel disease: practical lessons from the available evidence |
| Q42704404 | Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical |
| Q43948538 | Oral glutamine does not prevent bacterial translocation in rats subjected to intestinal obstruction and Escherichia coli challenge but reduces systemic bacteria spread |
| Q80531166 | Oxidative stress in lymphocytes, neutrophils, and serum of oral cavity cancer patients: modulatory array of L-glutamine |
| Q34223392 | Small bowel review: Normal physiology, part 2. |
| Q34478459 | Small bowel review: normal physiology part 2. |
| Q64070276 | Systematic review: outcomes and adverse events from randomised trials in Crohn's disease |
| Q39302506 | The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases |
| Q42368204 | Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease |
| Q82974598 | [Nutritional therapy in inflammatory bowel disease] |